ArticleScientific reports2020

New screening system using Twist1 promoter activity identifies dihydrorotenone as a potent drug targeting cancer-associated fibroblasts.

Eunmyong Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.